Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr;21(4):893-902.
doi: 10.1007/s10995-016-2190-y.

The Prevalence and Impact of Substance Use Disorder and Treatment on Maternal Obstetric Experiences and Birth Outcomes Among Singleton Deliveries in Massachusetts

Affiliations

The Prevalence and Impact of Substance Use Disorder and Treatment on Maternal Obstetric Experiences and Birth Outcomes Among Singleton Deliveries in Massachusetts

Milton Kotelchuck et al. Matern Child Health J. 2017 Apr.

Abstract

Objectives Despite widely-known negative effects of substance use disorders (SUD) on women, children, and society, knowledge about population-based prevalence and impact of SUD and SUD treatment during the perinatal period is limited. Methods Population-based data from 375,851 singleton deliveries in Massachusetts 2003-2007 were drawn from a maternal-infant longitudinally-linked statewide dataset of vital statistics, hospital discharges (including emergency department (ED) visits), and SUD treatment records. Maternal SUD and SUD treatment were identified from 1-year pre-conception through delivery. We determined (1) the prevalence of SUD and SUD treatment; (2) the association of SUD with women's perinatal health service utilization, obstetric experiences, and birth outcomes; and (3) the association of SUD treatment with birth outcomes, using both bivariate and adjusted analyses. Results 5.5% of Massachusetts's deliveries between 2003 and 2007 occurred in mothers with SUD, but only 66% of them received SUD treatment pre-delivery. Women with SUD were poorer, less educated and had more health problems; utilized less prenatal care but more antenatal ED visits and hospitalizations, and had worse obstetric and birth outcomes. In adjusted analyses, SUD was associated with higher risk of prematurity (AOR 1.35, 95% CI 1.28-1.41) and low birth weight (LBW) (AOR 1.73, 95% CI 1.64-1.82). Women receiving SUD treatment had lower odds of prematurity (AOR 0.61, 95% CI 0.55-0.68) and LBW (AOR 0.54, 95% CI 0.49-0.61). Conclusions for Practice SUD treatment may improve perinatal outcomes among pregnant women with SUD, but many who need treatment don't receive it. Longitudinally-linked existing public health and programmatic records provide opportunities for states to monitor SUD identification and treatment.

Keywords: Linked health data systems; Perinatal health services utilization; Perinatal outcomes; Pregnancy; SUD treatment; Substance use disorder.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Bada HS, Das A, Bauer CR, Shanrakan S, Lester B, et al. Gestational cocaine exposure and intrauterine growth: maternal lifestyle study. Obstetrics and Gynecology. 2002;100:916–924. - PubMed
    1. Behnke M, Smith VC Committee on Substance Abuse, Committee on Fetus and Newborn. Prenatal substance abuse: short- and long-term effects on the exposed fetus. Pediatrics. 2013;131:e1009–1024. - PMC - PubMed
    1. Bernstein J, Bernstein E, Belanoff C, Cabral HJ, Babakhanlou-Chase H, et al. The association of injury with substance abuse disorder among women of reproductive age—an opportunity to address a major contributor to recurrent preventable ED visits? Academic Emergency Medicine. 2014;21:1459–1468. - PMC - PubMed
    1. Bernstein J, Belanoff C, Cabral HJ, Babakhanlou-Chase H, Derrington T, et al. Treatment outcomes for substance use disorder among women of reproductive age in Massachusetts. Drug and Alcohol Dependence. 2015;147:151–159. - PMC - PubMed
    1. Burns L, Mattick RP. Using population data to examine the prevalence and correlates of neonatal abstinence syndrome. Drug and Alcohol Review. 2007;26(5):487–492. - PubMed